Incident somatic comorbidity after psychosis: results from a retrospective cohort study based on Flemish general practice data

BMC Family Practice

Research Article

Bert Aertgeerts¹  Carla Truyers¹  Stefaan Bartholomeeusen¹  Jan De Lepeleire¹  Frank Buntinx²  Emmanuel Lesaffre³  Ruud Van Winkel⁴  Marc De Hert⁴ 

[1] Department of General Practice, Katholieke Universiteit Leuven, Leuven, Belgium;Department of General Practice, Katholieke Universiteit Leuven, Leuven, Belgium;Research Institute Caphri, Maastricht University, Maastricht, The Netherlands;L-Biostat, Katholieke Universiteit Leuven, Leuven, Belgium; Department of Biostatistics, Erasmus University Rotterdam, Rotterdam, The Netherlands;University Psychiatric Center campus Kortenberg, Leuvensesteenweg 517, 3070, Kortenberg, Belgium;

关键词: Schizophrenia;    Irritable Bowel Syndrome;    Antipsychotic Medication;    Chronic Lung Disease;    Frailty Model;   

DOI  :  10.1186/1471-2296-12-132

 received in 2011-06-10, accepted in 2011-11-29,  发布年份 2011

来源: Springer

【 摘 要 】

BackgroundPsychotic conditions and especially schizophrenia, have been associated with increased morbidity and mortality. Many studies are performed in specialized settings with a strong focus on schizophrenia. Somatic comorbidity after psychosis is studied, using a general practice comorbidity registration network.MethodsHazard ratios are presented resulting from frailty models to assess the risk of subsequent somatic disease after a diagnosis of psychosis compared to people without psychosis matched on practice, age and gender. Diseases studied are cancer, physical trauma, diabetes mellitus, gastrointestinal disorders, joint disorders, irritable bowel syndrome, general infections, metabolic disorders other than diabetes, hearing and vision problems, anemia, cardiovascular disease, alcohol abuse, lung disorders, mouth and teeth problems, sexually transmitted diseases.ResultsSignificant higher risks after a diagnosis of psychosis were found for the emergence of diabetes, physical trauma, gastrointestinal disorders, alcohol abuse, chronic lung disease and teeth and mouth problems. With regard to diabetes, by including the type of antipsychotic medication it is clear that the significant overall effect was largely due to the use of atypical antipsychotic medication. No significant higher risk was seen for cancer, joint conditions, irritable bowel syndrome, general infections, other metabolic conditions, hearing/vision problems, anaemia, cardiovascular disease or diabetes, in case no atypical antipsychotic medication was used.ConclusionSignificantly higher morbidity rates for some somatic conditions in patients with psychosis are apparent. People with a diagnosis of psychosis benefit from regular assessments for the emergence of somatic disorders and risk factors, including diabetes in case of atypical antipsychotic medication.

【 授权许可】

CC BY   
© Truyers et al; licensee BioMed Central Ltd. 2011